BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 20521071)

  • 1. Formation and maintenance of blood-urine barrier in urothelium.
    Kreft ME; Hudoklin S; Jezernik K; Romih R
    Protoplasma; 2010 Oct; 246(1-4):3-14. PubMed ID: 20521071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apical plasma membrane traffic in superficial cells of bladder urothelium.
    Kreft ME; Jezernik K; Kreft M; Romih R
    Ann N Y Acad Sci; 2009 Jan; 1152():18-29. PubMed ID: 19161373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Golgi complex: An organelle that determines urothelial cell biology in health and disease.
    Kreft ME; Mironov AA; Hudoklin S
    Histochem Cell Biol; 2022 Sep; 158(3):229-240. PubMed ID: 35773494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early cellular and ultrastructural response of the mouse urinary bladder urothelium to ischemia.
    Korosec P; Jezernik K
    Virchows Arch; 2000 Apr; 436(4):377-83. PubMed ID: 10834542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The uroepithelium: not just a passive barrier.
    Apodaca G
    Traffic; 2004 Mar; 5(3):117-28. PubMed ID: 15086788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood-urine barrier formation in mouse urinary bladder development.
    Jezernik K; Pipan N
    Anat Rec; 1993 Apr; 235(4):533-8. PubMed ID: 8465986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uroplakin 1b is critical in urinary tract development and urothelial differentiation and homeostasis.
    Carpenter AR; Becknell MB; Ching CB; Cuaresma EJ; Chen X; Hains DS; McHugh KM
    Kidney Int; 2016 Mar; 89(3):612-24. PubMed ID: 26880456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The maintenance of the permeability barrier of bladder facet cells requires a continuous fusion of discoid vesicles with the apical plasma membrane.
    Born M; Pahner I; Ahnert-Hilger G; Jöns T
    Eur J Cell Biol; 2003 Jul; 82(7):343-50. PubMed ID: 12924629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urothelium with barrier function differentiated from human urine-derived stem cells for potential use in urinary tract reconstruction.
    Wan Q; Xiong G; Liu G; Shupe TD; Wei G; Zhang D; Liang D; Lu X; Atala A; Zhang Y
    Stem Cell Res Ther; 2018 Nov; 9(1):304. PubMed ID: 30409188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Freeze-fracture replica immunolabelling reveals urothelial plaques in cultured urothelial cells.
    Kreft ME; Robenek H
    PLoS One; 2012; 7(6):e38509. PubMed ID: 22768045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of membrane proteins in permeability barrier function: uroplakin ablation elevates urothelial permeability.
    Hu P; Meyers S; Liang FX; Deng FM; Kachar B; Zeidel ML; Sun TT
    Am J Physiol Renal Physiol; 2002 Dec; 283(6):F1200-7. PubMed ID: 12388410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bladder permeability barrier: recovery from selective injury of surface epithelial cells.
    Lavelle J; Meyers S; Ramage R; Bastacky S; Doty D; Apodaca G; Zeidel ML
    Am J Physiol Renal Physiol; 2002 Aug; 283(2):F242-53. PubMed ID: 12110507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uropathogenic E. coli promote a paracellular urothelial barrier defect characterized by altered tight junction integrity, epithelial cell sloughing and cytokine release.
    Wood MW; Breitschwerdt EB; Nordone SK; Linder KE; Gookin JL
    J Comp Pathol; 2012 Jul; 147(1):11-9. PubMed ID: 22014415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperplasia as a mechanism for rapid resealing urothelial injuries and maintaining high transepithelial resistance.
    Višnjar T; Kocbek P; Kreft ME
    Histochem Cell Biol; 2012 Feb; 137(2):177-86. PubMed ID: 22127649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urothelial ATP exocytosis: regulation of bladder compliance in the urine storage phase.
    Nakagomi H; Yoshiyama M; Mochizuki T; Miyamoto T; Komatsu R; Imura Y; Morizawa Y; Hiasa M; Miyaji T; Kira S; Araki I; Fujishita K; Shibata K; Shigetomi E; Shinozaki Y; Ichikawa R; Uneyama H; Iwatsuki K; Nomura M; de Groat WC; Moriyama Y; Takeda M; Koizumi S
    Sci Rep; 2016 Jul; 6():29761. PubMed ID: 27412485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The urothelium: a multi-faceted barrier against a harsh environment.
    Jafari NV; Rohn JL
    Mucosal Immunol; 2022 Jun; 15(6):1127-1142. PubMed ID: 36180582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-199a-5p regulates urothelial permeability and may play a role in bladder pain syndrome.
    Monastyrskaya K; Sánchez-Freire V; Hashemi Gheinani A; Klumpp DJ; Babiychuk EB; Draeger A; Burkhard FC
    Am J Pathol; 2013 Feb; 182(2):431-48. PubMed ID: 23201090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemistry as a paramount tool in research of normal urothelium, bladder cancer and bladder pain syndrome.
    Zupančič D; Romih R
    Eur J Histochem; 2021 Mar; 65(2):. PubMed ID: 33764020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-cancerous changes in urothelial endocytic vesicle leakage, fatty acid composition, and As and associated element concentrations after arsenic exposure.
    Grasso EJ; Bongiovanni GA; Pérez RD; Calderón RO
    Toxicology; 2011 Jun; 284(1-3):26-33. PubMed ID: 21440029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation-dependent localisation of tissue-type plasminogen activator in human bladder urothelium.
    Makuc J; Masera A; Trsinar B; Jezernik K
    Cell Biol Int; 2004; 28(5):381-6. PubMed ID: 15193281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.